Avalue Technology has launched a new line of medical-grade Edge computing systems designed to meet rising demand for real-time AI processing in hospitals, as healthcare providers accelerate digital transformation across imaging, surgery, and point-of-care services.
The Taiwan-listed industrial computer maker has introduced its MAB Series, a unified family of clinical-grade systems built around 12th and 13th generation Intel Core processors. The platform is aimed at enabling hospitals to run AI models directly on site, reducing reliance on cloud infrastructure and cutting the latency that can hinder time-critical clinical decisions.
The flagship MAB-T600, along with the MAB-T600-B1 variant, is certified to medical safety and electromagnetic compatibility standards, including ANSI/AAMI ES60601-1 and IEC 60601-1-2. Both systems support PCIe expansion and NVIDIA GPUs, targeting uses such as surgical navigation, diagnostic imaging, and continuous patient monitoring. The T600-B1 adds enterprise-grade features including ECC memory, RAID storage redundancy, and Intel Active Management Technology to bolster data integrity and system availability.
For mobile and space-constrained applications, Avalue has introduced the MAB-T660 and MAB-T660D, compact systems offering AI inference capabilities for bedside diagnostics, nursing stations, and portable clinical equipment.
Avalue said the unified architecture is intended to give hospitals and system integrators a clear performance ladder while controlling total cost of ownership. The company argues that shifting AI workloads to the Edge — within the hospital rather than in remote data centres — will be essential as providers scale up digital workflows and deploy more sophisticated analytical tools.
There’s plenty of other editorial on our sister site, Electronic Specifier! Or you can always join in the conversation by visiting our LinkedIn page.
